Celgene competitorsClear all
Celgene's top competitors include BioNTech, Sanofi, Idorsia, Amgen, Gilead Sciences and Regeneron Pharmaceuticals.
| Save Comparison |  Celgene Celgene is a biopharmaceutical company developing therapies for the treatment of cancer and inflammatory diseases. |  BioNTech BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. |  Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |
Founding Date | Founding Date 1986 | Founding Date 2008 | Founding Date 2004 | Founding Date 2017 | Founding Date 1980 | Founding Date 1987 | Founding Date 1988 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations Summit, US HQ Singapore, SG Boudry, CH | Locations Mainz, DE HQ Halle (Saale), DE Idar Oberstein, DE Marburg, DE Neuried, DE Planegg, DE Cambridge, US see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Kew, AU North Ryde, AU Wien, AT Machelen, BE see more | Locations Foster City, US HQ Abb, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Tarrytown, US HQ Dublin, IE Limerick, IE Uxbridge, GB Bernards, US Rensselaer, US Sleepy Hollow, US see more | |
Employees | Employees 8,85219% increase | Employees 1,30018% increase | Employees 100,4094% decrease | Employees 8007% increase | Employees 23,4009% increase | Employees 11,8007% increase | Employees 8,1009% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 139.5 b | Valuation ($) 86.6 b | Valuation ($) 56 b |
Twitter followers | Twitter followers 26.8 k | Twitter followers 57.8 k | Twitter followers 141.1 k | Twitter followers 1 k | Twitter followers 99.6 k | Twitter followers 67.9 k | Twitter followers 28.4 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) 46 | Number of tweets (last 30 days) 31 | Number of tweets (last 30 days) 97 | Number of tweets (last 30 days) 19 | Number of tweets (last 30 days) 53 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 172.2 | Average likes per tweet (last 30 days) 22.2 | Average likes per tweet (last 30 days) 7.5 | Average likes per tweet (last 30 days) 11.9 | Average likes per tweet (last 30 days) 25.3 | Average likes per tweet (last 30 days) 17.4 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 97.83% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 95.88% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 88.68% |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 250585 | Alexa Website Rank 123373 | Alexa Website Rank 158246 | Alexa Website Rank 200877 | Alexa Website Rank 112610 | Alexa Website Rank 183060 |
Employee Rating | Employee Rating 4 | Employee Rating 3.5 | Employee Rating 3.3 | Employee Rating 3.9 | Employee Rating 4 | Employee Rating 3.8 | Employee Rating 4 |
Financial | |||||||
Revenue (est.) | Revenue (est.) $15.3b (FY, 2018) | Revenue (est.) N/A | Revenue (est.) €36b (FY, 2020) | Revenue (est.) CHF23.8m (FY, 2019) | Revenue (est.) $25.4b (FY, 2020) | Revenue (est.) $24.7b (FY, 2020) | Revenue (est.) $8.5b (FY, 2020) |
Cost of goods | Cost of goods $587m (FY, 2018) | Cost of goods €59.3m (FY, 2020) | Cost of goods €12.2b (FY, 2020) | Cost of goods N/A | Cost of goods $6.2b (FY, 2020) | Cost of goods $4.6b (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit $14.7b (FY, 2018) | Gross profit N/A | Gross profit €25.2b (FY, 2020) | Gross profit N/A | Gross profit $19.3b (FY, 2020) | Gross profit $20.1b (FY, 2020) | Gross profit N/A |
Net income | Net income $4b (FY, 2018) | Net income €15.2m (FY, 2020) | Net income €12.4b (FY, 2020) | Net income (CHF494.6m) (FY, 2019) | Net income $7.3b (FY, 2020) | Net income $89m (FY, 2020) | Net income $3.5b (FY, 2020) |
Operating ⚠ | |||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 100 (FY, 2019) | Countries 35 (FY, 2019) | Countries N/A |
Patents (EU) | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) 21 (FY, 2019) | Patents (EU) N/A | Patents (EU) 11 (FY, 2019) |
Patents (US) | Patents (US) N/A | Patents (US) 45 (Oct, 2019) | Patents (US) N/A | Patents (US) N/A | Patents (US) 34 (FY, 2019) | Patents (US) 650 (Dec, 2020) | Patents (US) 21 (FY, 2019) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 8 (Oct, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 22 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 12 (FY, 2020) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 7 (FY, 2019) | Phase I Trials Products (Oncology) N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 1 (Oct, 2019) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2019) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 6 (FY, 2020) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 2 (FY, 2019) | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 14 (Feb, 2020) | Phase III Trials Products 27 (FY, 2019) | Phase III Trials Products N/A |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 24 (FY, 2019) | Products 7 (FY, 2019) |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline 12 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A |
Funding | |||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.4b | Total funding raised $ 310m | Total funding raised N/A | Total funding raised $ 175.5m | Total funding raised N/A | Total funding raised $ 8.9m |
For sources of this data, please see the company profile
View company profiles
BioNTech
HQ
Mainz, DE
Employees
1,300↑ 18% increase
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
View companySanofi
HQ
Paris, FR
Employees
100,409↓ 4% decrease
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View companyIdorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View companyAmgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View company